ArticleArquivos de neuro-psiquiatria2022
It is time anti-CGRP monoclonal antibodies be considered first-line prophylaxis for migraine.
Gabriel Taricani KubotaPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it